151 related articles for article (PubMed ID: 1736604)
1. Effect of dipyridamole therapy on myocardial ischemia in patients with stable angina pectoris receiving concurrent anti-ischemic therapy.
Barbour MM; Garber CE; Agarwal KC; Malhotra R; Heller GV
Am J Cardiol; 1992 Feb; 69(5):449-52. PubMed ID: 1736604
[TBL] [Abstract][Full Text] [Related]
2. Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group.
Thadani U; Ezekowitz M; Fenney L; Chiang YK
Circulation; 1994 Aug; 90(2):726-34. PubMed ID: 8044941
[TBL] [Abstract][Full Text] [Related]
3. Discordance between effects of anti-ischemic therapy on ambulatory ischemia, exercise performance and anginal symptoms in patients with stable angina pectoris. The Angina and Silent Ischemia Study Group (ASIS).
Borzak S; Fenton T; Glasser SP; Shook TL; MacCallum G; Young PM; Stone PH
J Am Coll Cardiol; 1993 Jun; 21(7):1605-11. PubMed ID: 8496526
[TBL] [Abstract][Full Text] [Related]
4. Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Differential effects on ambulatory ischemia, exercise performance, and anginal symptoms. The ASIS Study Group.
Stone PH; Gibson RS; Glasser SP; DeWood MA; Parker JD; Kawanishi DT; Crawford MH; Messineo FC; Shook TL; Raby K
Circulation; 1990 Dec; 82(6):1962-72. PubMed ID: 2122926
[TBL] [Abstract][Full Text] [Related]
5. Effect of dipyridamole at the usual oral dose on exercise-induced myocardial ischemia in stable angina pectoris.
Tsuya T; Okada M; Horie H; Ishikawa K
Am J Cardiol; 1990 Aug; 66(3):275-8. PubMed ID: 2195863
[TBL] [Abstract][Full Text] [Related]
6. Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.
Thadani U; Zellner SR; Glasser S; Bittar N; Montoro R; Miller AB; Chaitman B; Schulman P; Stahl A; DiBianco R
Circulation; 1991 Dec; 84(6):2398-408. PubMed ID: 1959195
[TBL] [Abstract][Full Text] [Related]
7. Antianginal efficacy and improved exercise performance with timolol. Twice-daily beta blockade in ischemic heart disease.
Harris FJ; Low RI; Paumer L; Amsterdam EA; Mason DT
Am J Cardiol; 1983 Jan; 51(1):13-8. PubMed ID: 6129794
[TBL] [Abstract][Full Text] [Related]
8. Dipyridamole in chronic stable angina pectoris; a randomized, double blind, placebo-controlled, parallel group study.
Picano E;
Eur Heart J; 2001 Oct; 22(19):1785-93. PubMed ID: 11549300
[TBL] [Abstract][Full Text] [Related]
9. Low-dose dipyridamole infusion acutely increases exercise capacity in angina pectoris: a double-blind, placebo controlled crossover stress echocardiographic study.
Tommasi S; Carluccio E; Bentivoglio M; Corea L; Picano E
J Am Coll Cardiol; 2000 Jan; 35(1):83-8. PubMed ID: 10636264
[TBL] [Abstract][Full Text] [Related]
10. Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.
Frishman WH; Glasser S; Stone P; Deedwania PC; Johnson M; Fakouhi TD
Am J Cardiol; 1999 Feb; 83(4):507-14. PubMed ID: 10073852
[TBL] [Abstract][Full Text] [Related]
11. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
[TBL] [Abstract][Full Text] [Related]
12. Duration of effects of isradipine during twice daily therapy in angina pectoris.
Thadani U; Chrysant S; Gorwit J; Giles T; Archer S; Iteld B; Singh S; Copen D; Wakeford C; Hobbs S
Cardiovasc Drugs Ther; 1994 Apr; 8(2):199-210. PubMed ID: 7918132
[TBL] [Abstract][Full Text] [Related]
13. Antianginal and anti-ischemic effects of mibefradil in the treatment of patients with chronic stable angina pectoris.
Alpert JS; Bakx AL; Braun S; Frishman WH; Schneeweiss A; Tzivoni D; Kobrin I
Am J Cardiol; 1997 Aug; 80(4B):20C-26C. PubMed ID: 9286850
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a single dose of slow-release isosorbide dinitrate in the treatment of silent or painful myocardial ischemia in stable angina pectoris.
Dubiel JP; Moczurad KW; Bryniarski L
Am J Cardiol; 1992 May; 69(14):1156-60. PubMed ID: 1575184
[TBL] [Abstract][Full Text] [Related]
15. Effect of nifedipine on total ischemic activity and circadian distribution of myocardial ischemic episodes in angina pectoris.
Nesto RW; Phillips RT; Kett KG; McAuliffe LS; Roberts M; Hegarty P
Am J Cardiol; 1991 Jan; 67(2):128-32. PubMed ID: 1987713
[TBL] [Abstract][Full Text] [Related]
16. Assessment of anti-ischemic and antianginal effect at trough plasma concentration and safety of trimetazidine MR 35 mg in patients with stable angina pectoris: a multicenter, double-blind, placebo-controlled study.
Sellier P; Broustet JP
Am J Cardiovasc Drugs; 2003; 3(5):361-9. PubMed ID: 14728070
[TBL] [Abstract][Full Text] [Related]
17. Randomized double-blind study of pindolol in patients with stable angina pectoris.
Harston WE; Friesinger GC
Am Heart J; 1982 Aug; 104(2 Pt 2):504-11. PubMed ID: 7102537
[TBL] [Abstract][Full Text] [Related]
18. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
Ruzyllo W; Tendera M; Ford I; Fox KM
Drugs; 2007; 67(3):393-405. PubMed ID: 17335297
[TBL] [Abstract][Full Text] [Related]
19. Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine.
Di Somma S; de Divitiis M; Bertocchi F; Carotenuto A; Cudemo G; Petitto M; Napodano M; de Divitiis O
Cardiologia; 1996 Jul; 41(7):635-43. PubMed ID: 8831181
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implications of ambulatory myocardial ischemia and arrhythmias and relations to ischemia on exercise in chronic stable angina pectoris (the Angina Prognosis Study in Stockholm [APSIS]).
Forslund L; Hjemdahl P; Held C; Eriksson SV; Björkander I; Rehnqvist N
Am J Cardiol; 1999 Nov; 84(10):1151-7. PubMed ID: 10569322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
